Background

Coenzyme Q10 (CoQ10) has been extensively studied as a mitochondrial cofactor and lipid-soluble antioxidant, yet existing literature often addresses its mechanisms or clinical applications in isolation.

A comprehensive framework integrating its energy-driving role, antioxidant capacity, and systemic disease-intervention value has been lacking.

Objective

This review synthesizes mechanistic, clinical, and formulation-based evidence of CoQ10 within the Keyora Three-Axis, Seven-Module Framework, aiming to establish a holistic nutritional paradigm that bridges functional and clinical nutrition.

Methods

We critically examined mechanistic pathways (electron transport chain efficiency, reactive oxygen species regulation, membrane lipid integration, neurotransmitter and enzymatic cofactor interactions), population-based evidence (neurodegenerative diseases, cardiovascular conditions, type II diabetes, cancer patients undergoing chemotherapy, elderly populations, and dermatological aging), and formulation strategies (bioavailability enhancement via lipid micellization and synergistic cofactors).

Data were drawn from randomized controlled trials, cohort studies, mechanistic experiments, and consensus statements.

Results

Axis I – Mitochondrial Energy Axis:

CoQ10 restores ATP production and reduces ROS leakage; Omega-3/6/9 fatty acids (α-linolenic acid (ALA), linoleic acid (LA), oleic acid (OA)) stabilize mitochondrial membranes; vitamins/minerals act as cofactors sustaining energy metabolism.

Axis II – Antioxidant and Cellular Protection Axis:

A cross-phase antioxidant network integrates CoQ10, vitamin C/E, selenium, and zinc, with fatty acids optimizing membrane resistance and n-6/n-3 balance.

Axis III – Disease Intervention and Anti-Aging Axis:

Evidence supports CoQ10 and nutrient synergy in delaying Alzheimer’s and Parkinson’s disease, compensating drug-induced nutrient deficiencies (statins, metformin, chemotherapeutics), and protecting skin from aging via collagen synthesis, barrier lipid restoration, and photoaging defense.

Formulation strategy:

Bioavailability of CoQ10 is significantly enhanced by co-micellization with poly- and monounsaturated fatty acids and by enzymatic support from vitamins / minerals, enabling systemic delivery across digestive absorption, plasma circulation, and blood–brain barrier transport.

Conclusion

CoQ10 is not merely a single antioxidant supplement but functions as the central “driving force” within a closed-loop system of energy-antioxidant-structural-disease-aging regulation.

The Keyora Co-Q10 17 in 1 formulation exemplifies this integrative approach, demonstrating cross-mechanistic, cross-disease, and cross-population applicability.

This framework redefines CoQ10 as a cornerstone of nutritional pharmacology and a translational bridge between functional and clinical nutrition.